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While the concept of PCMHs is only in
its infancy... the fundamentals have the
potential to improve health care
practice and ultimately the health of
patients nationwide.
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Introduction
Health care is a dynamic system and is always progressing in ways that are aimed to improve the health status of patients. 1 While
health care professionals are often reluctant to embrace new operations impacting their daily business, the possibility for overwhelming benefit in the care of their patients is often enough motivation for providers to accept these changes. 1 The American
Academy of Pediatrics first described a "medical home" in 1967, which was based upon the notion of "comprehensive care for
2
every patient." The concept of a patient-centered medical home (PCMH) started to gain steam nearly a decade ago in the early
1
2000s, still predominantly within the context of treating children with chronic conditions. Today, the term medical home is de3
fined as an "approach for providing comprehensive and coordinated primary care." The boundaries of PCMHs have expanded
within recent years. In 2007 the American Academy of Pediatrics, American Academy of Family Practice, American College of Physicians and American Osteopathic Association published a statement that included a summary of the vital components that characterize a PCMH. Furthermore, these organizations called for "accessible, continuous, team-based care that focuses on the whole
person, with the PCMH taking responsibility for care coordination ." This definition includes improving clinical outcomes as well as
1
the overall patient experience.
Progression of PCMHs
Currently, PCMHs are seen by many as a revolution in health
care. So, what exactly is a PCMH and how would it affect current health care providers? Patient-centered medical homes
are currently thought to have the power to improve health
outcomes for patients as well as potentially reduce overall
costs. Without both of these components, the concept of a
1
PCMH would not reach a prominent reality. The National
Committee for Quality Assurance (NCQA) is considered the
primary organization responsible for creating PCMH stan- =========-----======-------=====-~
4
dards. The first set of standards, created in 2008 and later revised in 2011, placed a large emphasis on patient involvement. 4 Crossing the Quality Chasm, a report created by the Institute of Medicine, put forth "10 Simple Rules for the 21st Century Health Care
5
System" to guide the restructuring of the health care system. This report has been a significant building block for the development
of the NCQA's PCMH guidelines. The report describes a system different from that in existence today and offers suggestions for
improved health care. A few of the proposed changes include anticipating patient needs rather than reacting to events, allowing
the patient to be the source of control by providing them with the necessary information to make treatment decisions, sharing
knowledge freely with the patient and increasing cooperation among clinicians. The fundamental elements of a PCMH according to
the NCQA include an increased access and continuity to medical care, which involves access to electronic documents as well as the
5
ability of a patient to select a clinician and for the patient's health to be based on a team approach. Next, a PCMH must recognize
and manage the patient population in general by retrieving demographic and clinical data, determining risk factors and instituting
4
proactive measures to combat negative health trends. Additionally, managed care, which involves pre-appointment planning, creating patient goals, identifying obstacles to achieving the goals, medication action plans during visits and the use of e-prescribing, is
4
deemed to be necessary. Similarly, counseling should be provided to enable patients to make healthy choices. This notion of selfcare by patients can be a vital role for pharmacists within PCMHs, especially those in the community and ambulatory setting. 4 Educating patients about healthy choices may also stimulate patient investment and involvement in their own health care. Coordination among health care providers is necessary, especially during transitions in care, such as when a patient is discharged from the
hospital. Patient assessment and feedback of the health care process is also a vital piece of the puzzle. Other required factors include accessibility of health care professionals during office hours, using the data collected for the management of patient populations, care management, a patient self-care program, tracking of referrals, following up appointments and a quality improvement
program. The increased access to care is a calling for pharmacists, due to the fact that pharmacists are one of the most readily accessible health care professionals. 4

Patient-centered medical homes are
currently thought to have the power to
improve health outcomes for patients as
well as potentially reduce overall costs.

PCMHs and the Current Health care System
The medical home model requires allocating time and resources up front to the health care reconfigurations that are needed to
2
improve care across the health care delivery continuum. However, the current care process for many physicians today can be described as "uncoordinated, episodic care." With the introduction of PCMHs, the health care process is now shifting toward
"comprehensive, integrated, coordinated care that is structured to keep patients out of the hospital." As described by Dr. Paul
Grundy, President of the Patient-Centered Primary Care Collaborative, "If you manage chronic disease better, fewer beds will be
needed for people who are being treated as outpatients." According to this thought process, by spending more money up front,
patient health will take leaps forward; in addition, a significant amount of money can potentially be saved in the long run on costs
2
such as hospitalizations for acute events. Similarly, the American College of Physicians (ACP) stated the necessity of the role of
pharmacists in today's health care system, noting that the rising health care costs are a sign for the need for change. 4 Pharmacists
already play a vital role in ensuring that patients use their prescribed medication in the correct manner with numerous chronic
diseases, while also monitoring for adverse events or compliance issues. It has been well documented in the Asheville Project and
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the Minnesota Medicaid experience that pharmacists can have a positive impact in patient health, as well as being financially beneficial.4

The Role of Pharmacists in PCMHs
Pharmacists can have a major impact on the success of PCMHs. A pharmacist working as a part of the PCMH can increase the quality of patient care, resulting in improved patient health outcomes, especially through monitoring of chronic disease conditions. 3
Numerous pharmacy health care organizations are stressing the importance of the pharmacists' involvement in PCMHs, especially
through the clinical service of medication therapy management (MTM), which has been shown to increase patient compliance and
4
understanding of medications and lead to improved health outcomes. This is significant since it is estimated that 71 percent of
adults in the United States have two or more chronic disease states. Additionally, 48 percent of adults in the United States were
taking four or more prescriptions to manage chronic disease states, which tend to lend itself to the role of a pharmacist in the management of medication plans. 3 This situation is often demonstrated when pharmacists manage the care of individuals with chronic
disease states, as long as a new disease is not suspected. For example, a pharmacist can monitor a patient with diabetes and be
responsible for the transition from oral medications to insulin. This relationship can replace the need for the physician to refer the
patient to a specialist. A physician and a pharmacist can create a scope of practice outlining what the pharmacist is authorized to
do, such as when a pharmacist is able to initiate, modify or continue drug therapy in certain patient populations, most notably patients with chronic disease states. 3 The Affordable Care
Act, passed in 2010, reiterated the importance of pharmacists when it stated in section 3505 that grants from the
Agency for Healthcare Research and Quality (AHRQ) can be
provided to "implement medication management services
provided by licensed pharmacists, as a part of a collaborative, interprofessional approach to the treatment of
chronic diseases for targeted individuals, to improve the
quality of care and reduce overall cost in the treatment of
such diseases." Pharmacists also play a critically important
role of decreasing the number of medication errors by pro4
viding MTM services.

... 48 percent of adults in the United States
were taking four or more prescriptions
to manage chronic disease states, which
tends to lend itself to the role of a
pharmacist in the management of
medication plans.

Similarly, pharmacists can incorporate a large portion of the PCM H's goal of continuity of care into their practice setting. MTM services can be provided to patients between their appointments with their primary care physician. This can be especially true for
patients with a complex medication regimen consisting of a high number of medications, or treatments where progress should be
monitored for dosage adjustments. 3 It is estimated that only 33 to 50 percent of patients with a chronic condition fully adhere to
6
their medication regimen, which demonstrates vast room for improvement and a spot for MTM in health care. Medication therapy management often involves a review of all current medications, including vitamins, herbals and over-the-counter (OTC) products in order to ensure proper use, adherence and safety. These sorts of reviews often resolve errors in therapy, such as
"inappropriate medication selection, omissions, duplications, subtherapeutic or excessive dosages, drug interactions, adverse
6
events, adherence problems" and expensive regimens. These services can be offered by pharmacists in a number of different set3
tings, including physician offices, outpatient clinics, senior centers, community pharmacies and within the patient's own home.
Additionally, pre-visit planning by a pharmacist in the medical model can allow recommendations on medication regimens to be
shared with the physician. 6 Similarly, when a patient leaves the hospital, the pharmacist overseeing the patient's medications in
the home setting, normally the community pharmacist, should be informed of any changes in therapy, such as new drugs, altered
3
doses or discontinued medications, in order to ensure continuity of care during this transition.

Impact on Patients
Although all patients can benefit from PCMHs, certain patients are specifically targeted as having a very high potential for positive
health impacts. The characteristics of patients that can benefit the most from PCMHs are those with a high quantity of medications, numerous chronic disease states, complicated medication regimens, poor adherence, medications with an elevated risk for
adverse effects, physiologic states that are compromised such as renal function, poor therapeutic response to a medication regimen, more than one pharmacy or doctor, regular transitions of care and high health care spending (including emergency department visits and hospital admissions). 3 It is estimated that 90 million people in the United States suffer from chronic disease conditions.7 Patients with a strict budget can also benefit from MTM services provided by pharmacists; it is estimated that 58 percent of
6
doctors claimed that their patients struggle to afford their medications. Additional roles of pharmacists in helping to reduce the
cost of medication for patients involve incorporating evidence-based medicine and guidelines from pharmacy and therapeutic
committees. 7 Pharmacists can have a vital role with therapeutic interchange, in which a drug that is originally prescribed is re7
placed with a therapeutic equivalent with the approval of the prescriber. Similarly, a clinical pharmacist can provide a training session with newly hired physicians regarding a prescription to OTC conversion list, a drug formulary list, antibiotic appropriateness
7
sheets and charts comparing the costs of medications. As a result, patients will have more outpatient therapy rather than in pa-
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tient stays in hospitals due to medical emergencies, especially those which could have been prevented with a guided treatment
2
approach.
Another large element of the pending success of PCMHs
centers around patient engagement and patients taking
more responsibility for achieving their health goals. A
medication action plan (MAP) provides an opportunity for
patients to be involved in their medication management,
empowering them to discuss and set reasonable personal
3
goals with their pharmacist. This procedure allows patients to develop a higher level of understanding of their
medications, as well as have a plan to which they are more
likely to adhere. By encouraging patients to take an active
role in their health, the number of hospital and emergency
2
department visits can be drastically decreased which in the long run saves money and resources.

By encouraging patients to take an active
role in their health, the number of hospital
and emergency department visits can be
drastically decreased which in the long
run saves money and resources.

Communication: A Vital Component of PCMHs

Also, the development of electronic health records (EH Rs) and health information exchanges (HIE) are vital for meeting the connec3
tion and cooperation of health care professionals in a PCMH. A central medication profile is essential for patient safety and opti3
mal outcomes, especially since many patients have multiple prescribers and pharmacies. Additionally, not all medications are recorded on prescription claim databases since many drugs are not purchased through insurance due to low generic prices. 3 Since
allergy and drug interactions may not be available or consistent among the information provided by patients to all health care pro4
fessionals, the HIEs can be vital. In situations like these, a HIE can allow for a comprehensive medication list to be available to all
3
health care professionals in a secure manner, with patient approval. By operating within the PCMH, pharmacists can analyze both
3
a patient's drug history with diagnoses and test results, which can allow for drug therapy problems to be identified. This sort of
3
record keeping also aids in the patient's continuity of care.
The grave importance of PCMHs is demonstrated in situations involving a transition in care. It is estimated that 23 percent of patients that are discharged from the hospital have an adverse event, mostly medication related, within 30 days from their discharge.3 As a result, approximately 20 percent of these adverse effects result in a trip to the emergency department or a hospital
3
readmission. This is often a result of a deficient amount of communication among hospitals, primary care physicians and patients. 3
One potential solution to this currently poor model for transition of care after a hospital discharge can be improved electronic databases, as described above, which can help with medication reconciliation being relayed to the outpatient setting. 8
Specialized Requirements and Training

In order to work within a PCMH, there are certain qualifications that are recommended for a pharmacist. The root of the current
roles of pharmacists began in 1990, with the introduction of the term "pharmaceutical care," which changed the role of a pharma6
cist from only filling and dispensing prescriptions to more patient-centered services, such as MTM. The recommended knowledge
for a pharmacist in the PCMH set consists of "evidence-based pharmacotherapy knowledge base; direct patient care experience;
excellent written and oral communication skills; MTM training; pharmacy specialty board certifications; residency training in ambulatory care, primary care, or family medicine practice settings; and a basic understanding of continuous quality improvement princi3
ples and health information technology (HIT) applications."
Employment Models

I

There are multiple employment models for pharmacists in PCMHs.
First, there is the employed model in which a pharmacist works in a
3
clinical setting within the PCMH. Next, there is the embedded model
which is based on the pharmacist working in a "partnership" within a
3
hospital pharmacy or pharmacy school. The model has been demonstrated to be successful in the Iowa Family Medicine Program, in
which clinical pharmacists were employed at six community family
residencies based on funding from a college of pharmacy and resi6
dency programs. The primary goal was to improve blood pressure. 6
The patients were split into two groups, a control group and an intervention group, in which the clinical pharmacist was involved in the
patients' therapies. Based on the role of the pharmacist, the blood
pressure was controlled in more patients (63.9 percent) than the
6
control group (29.9 percent). Demonstrating the significance of this
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data, the average blood pressure decreased 20.7 /9.7 mmHg in the intervention group compared to 6.8/4.5 mmHg for the control
6
group. There is also the regional model, in which a pharmacist works out of a health system office which operates for multiple
3
PCMHs within a certain region. Oftentimes, the pharmacist uses a population approach to create medication management programs, in addition to providing "education programs, evaluation services and outcomes research." A pharmacist can also work
within a contracted model for a PCMH where he would meet with patients in a variety of ways, including going to the patient's
3
home, meeting the patient at the physician's office or community pharmacy, or in some cases on the telephone. These are just a
few examples of the types of employment for pharmacists within PCMHs.
Despite the numerous advances in the organization of PCMHs, one area of PCMHs that still needs to be ironed out is how to rei m3
burse pharmacists for their services. One option is a fee-for-service model of reimbursement. The Asheville Project, which started
in Asheville, North Carolina, in 1997, demonstrated the impact of pharmacists in a fee-for-service reimbursement plan. 6 Pharmacists were able to develop treatment goals and monitor for
adverse reactions and patient adherence. There was a significantly larger number of patients with diabetes (24.3 percent)
that lowered their hemoglobin AlC levels to below 7 percent,
6
when a pharmacist was involved in their treatment regimen.
Overall, the return on investment for the Asheville diabetes
program was 4:1, indicating the major impact on the health
6
care system. Alternately, the care coordination fee method of
reimbursement is a method of monthly payment based on the
3
number of patients in the practice. Other reimbursement
methods incorporate performance and incentives, which
means that payment is based on lowering the number of
preventable emergency department visits, unnecessary
appointments with specialty physicians and the number of hospitalizations.3 However, it is imperative for pharmacists and
pharmacy organizations to advocate for the essential role of
4
the pharmacist in PCMHs on the local, state and national level.
Barriers

Patient-centered medical homes have come a long way in a short time, but there are still a number of barriers that need to be
overcome in order for them to operate efficiently and effectively. All health care professionals have to work together, oftentimes
overlapping in patient coverage. 4 Similarly, several health care professionals disagree on which components are necessities when it
comes to a functional, effective PCMH. The major concern is the capacity of small practices to implement a PCMH. It is important
to consider that independently owned practices with less than or equal to five physicians provide nearly 75 percent of all am bulatory care visits! 1 Additionally, the vast majority of community pharmacies do not have access to full patient information, but in6
stead have to call or fax a physician's office with questions about adverse reactions or drug-drug interactions.
PCMHs in the Clinical Setting

Currently, there are multiple forms of PCMHs that have been established. Starting a PCMH could come about via different avenues:
one option is to start a "medical home" for employees and then expand the program. Similarly, a hospital or health system can
begin by focusing its attention on patients that come to the emergency department for primary care, especially those patients that
are uninsured and/or underinsured. Another reason for starting a PCMH could be the need to develop a strategy to cope with the
hard economic times. For example, a PCMH was created by Ellis Medicine in Schenectady, New York, after two other local hospitals
were forced to close. As a result, Ellis Medicine became the only provider of health care services for the surrounding area of
2
Schenectady, which consists of 62,000 people, of which 19.8 percent are considered to be below the poverty rate. Ellis Medicine
had to shift its targets from length of stay toward a more public health oriented style, including objectives such as the prevention
of diabetes and obesity. Additionally, Ellis Medicine collaborated to bring various aspects of health care to its location, including a
family practice clinic, a dental clinic, a pediatric practice, adolescent behavioral health services, a Medicaid enrollment facilitator
and an immunization site. This system was developed to prevent, or at least decrease, the number of patients arriving at the emergency department in a medical crisis. Therefore, less hospital stays will ensue, which is necessary, especially since Ellis Medicine is
2
the only hospital still operating in that area.
Additionally, a PCMH in Seattle, known as Group Health Cooperative, was founded on the concern that physicians were being
forced to meet with their patients within a very confined ten to fifteen minute window. It was realized that as the productivity of
physicians was severely compromised due to time constraints, there was a direct relationship to the management of patient
health. 2 As a result, the Group Health Cooperative began a pilot project involving a primary care team consisting of physicians,
nurses, pharmacists and a frontline staft.2 Through this program, doctors meet with a smaller number of patients, but for a longer
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period of time of about 30 minutes. Doctors are additionally
given the time to email or call patients, while also communicating
on a regular basis with pharmacists and nurses to develop patient
care plans. Based on the work of implementing the PCMH, emergency department visits decreased by 29 percent and hospital
2
days were reduced by 19 percent.

... emergency department visits
decreased by 29 percent and hospital
days were reduced by 19 percent.

Conclusion
The evolution of health care through the ages has often been met with opposition and obstacles, but nonetheless, progress takes
place when changes are worth the fight. While the concept of PCMHs is only in its infancy in terms of where this idea can develop,
its fundamentals have the potential to improve health care practice and ultimately the health of patients nationwide. There are
many flaws that exist in the health care system today; however, progression of PCMHs from its current position has the potential
to revolutionize both pharmacy and health care as a whole. This is consistent with the views of American Academy of Pediatrics,
American Academy of Family Practice, American College of Physicians and the American Osteopathic Association as evidenced by
the joint published statement that they support "accessible, continuous, team-based care that focuses on the whole person, with
1
the PCMH taking responsibility for care coordination." Currently, PCMHs are on the horizon of health care and whether or not
they live up to their potential is up to current and future health care professionals, including pharmacists, to both fight for and expand upon the current PCMH format!
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